AstraZeneca, Sanofi tee up 3-way RSV battle in 2023 as FDA signals expedited review for antibody
Fierce Pharma
JANUARY 5, 2023
AstraZeneca, Sanofi tee up 3-way RSV battle in 2023 as FDA signals expedited review for antibody. Thu, 01/05/2023 - 10:13.
Let's personalize your content